相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Early Changes in Kidney Distribution under the New Allocation System
Allan B. Massie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Interferon-Free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real-World Experience From the Hepatitis C Therapeutic Registry and Research Network
Robert S. Brown et al.
LIVER TRANSPLANTATION (2016)
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence
Fred Poordad et al.
HEPATOLOGY (2016)
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Michael Manns et al.
LANCET INFECTIOUS DISEASES (2016)
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation
Jerome Dumortier et al.
LIVER TRANSPLANTATION (2016)
Heterogeneity and Disparities in the Use of Exception Scores in Pediatric Liver Allocation
E. K. Hsu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
OPTN/SRTR 2013 Annual Data Report: liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Xavier Forns et al.
HEPATOLOGY (2015)
Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006-2012
Anil G. Suryaprasad et al.
CLINICAL INFECTIOUS DISEASES (2014)
Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late
Adriano M. Pellicelli et al.
DIGESTIVE AND LIVER DISEASE (2014)
Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience
Audrey Coilly et al.
JOURNAL OF HEPATOLOGY (2014)
Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation
Martina Gambato et al.
JOURNAL OF HEPATOLOGY (2014)
An Interferon-free Antiviral Regimen for HCV after Liver Transplantation
Paul Y. Kwo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C
R. J. Fontana et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
A Survey of Hepatitis C Treatment Clinical Practice Patterns Using the Newly Approved Protease Inhibitors
Emerson Y. Chen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Multicenter Experience Using Telaprevir or Boceprevir With Peginterferon and Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplantation
Surakit Pungpapong et al.
LIVER TRANSPLANTATION (2013)
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma
Scott W. Biggins et al.
LIVER TRANSPLANTATION (2012)
Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined
Jacqueline G. O'Leary et al.
TRANSPLANT INTERNATIONAL (2012)
The Faltering Solid Organ Donor Pool in the United States (2001-2010)
Reza F. Saidi et al.
WORLD JOURNAL OF SURGERY (2012)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis
Patrick G. Northup et al.
TRANSPLANT INTERNATIONAL (2010)
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation
M. Berenguer et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
What determines the natural history of recurrent hepatitis C after liver transplantation?
M Berenguer
JOURNAL OF HEPATOLOGY (2005)